Abstracts of the 6th Canadian Neuro-Oncology Meeting May 18–21, 1994 Lake Louise, Alberta

Autor: Kozo Fukuyama, Kazuhito Matsuzawa, Sherri Lynn Hubbard, Peter Dirks, James T. Rulka, K. Maisuzawa, S. L. Hubbard, J. T. Rutka, R. F. Del Maestro, I. S. Vaithilingam, W. McDonald, J. B. Weiss, T. Mikkelsen, E. Kohn, K. Nclson, M. L. Rosenblum, Abhijit Guha, Steve Shamah, Charles Stiles, N. P. Dooley, G. H. Baltuch, M. Roslworowski, J. G. Villemure, V. W. Yong, G. Baltuch, M. Rostworowski, W. T. Couldwell, D. R. Hinton, M. H. Weiss, R. Law, William T. Couldwell, David R. Hinton, Ron Law, Martin H. Weiss, J. M. Piepmeier, P. E. Pedersen, C. A. Greer, PB Dirks, SL Hubbard, A. Taghian, W. Budach, J. Freeman, D. Gioioso, H. D. Suit, J. Turner, G. Barron, P. Zia, C. S. Wong, J. Van Dyk, M. Milosevic, N. J. Laperriere, S. T. Myles, C. Lauryssen, E. G. Shaw, B. W. Scheithauer, V. Suman, J. Katzmann, M. Preul, G. Shenouda, A. Langleben, D. Arnold, C. Watling, D. van Meyel, D. Ramsay, G. Cairncross, J. P. Bahary, I. Wainer, M. Pollak, B. Leyland-Jones, A. Tsatoumas, A. Choi, S. S. Rosenfeld, G. Y. Gillespie, C. L. Gladson, J. M. Drake, H. J. Hoffman, R. P. Humphreys, S. Holowka, D. S. Fullon, R. C. Urtasun, Mark G. Hamilton, S. Beals, E. Joganic, R. Spetzler, J. C. Buckner, P. L. Schaefer, R. P. Dinapolit, J. R. O'Fallon, P. A. Burch, C. L. Chandler, K. Hopkins, H. B. Coakham, J. Bullimore, J. T. Kemshead, Mark Bernstein, Normand Laperriere, Stephen MeKenzie, Jennifer Glen, D. Lee, D. Macdonald, P. K. Sneed, P. G. Gulin, D. A. Larson, M. W. McDermott, M. D. Prados, W. M. Wara, K. A. Weaver, L. Gaspar, L. Zamorano, L. Garcia, F. Shamsa, C. Warmelink, D. Yakar, J. A. Espinosa, L. Souhami, J. L. Caron, A. Olivier, E. B. Podgorsak, C. Lindquist, J. S. Loeffler, L. D. Lunsford, H. B. Newton, M. D. Kotur, A. C. Papp, T. W. Prior, N. Roosen, R. Chopra, J. Windham, Matthew Parliament, Allan Franko, Brace Mielke, W. Feindel, D. Tampieri, L. L. Mechtler, S. Wilheim-Leitch, K. Shin, W. R. Kinkel, M. A. Hammoud, R. Sawaya, W. Shi, P. P. Thall, N. Leeds, M. Patel, B. Truax, P. Kinkel, T. M. Cheng, B. P. O'Ncill, D. G. Piepgras, P. J. Frost, W. J. S. Simpson, D. G. Payne, M. Pintilie, D. A. Ramsay, J. Bonnin, D. R. Macdonald, L. Assis, J. G. Villemurel, S. Choi, R. Leblancl, A. Olivieri, G. Bertrandl, J. Hazel, W. Grand, R. Plunkett, F. Munschauer, P. Ostrow, L. Mcchtler, S. Meckling, O. Dold, P. Forsyth, P. Brasher, N. Hagen, L. P. Hudson, A. L. Cooke, P. J. Muller, W. Tucker, R. Moulton, M. Cusimano, J. Bilbao, P. A. Pahapill, C. Sibala, C. West, B. Fisher, W. Pexman, J. Taylor, T. Lee, Stephen W. McKenzie, Tian Zengmin, Liu Zonghui, S. Kirby, B. J. Fisher, D. J. Stewart, W. Roa, B. McClean, S. Buckney, S. Halls, S. Richardson, B. C. Wilson, A. C. Whitton, R. D. Borr, H. Rhydderch, T. Case, D. Feeny, W. Furlong, G. W. Torrance

Publikováno v: Journal of Neuro-Oncology. 19:175-192

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1a0816230d7bf6bf79b2c3940a54b933
https://doi.org/10.1007/bf01306460

Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate

Autor: N. Sengupta, E. Chartash, G. W. Torrance, S. Amorosi, P. Tugwell

Publikováno v: Rheumatology (Oxford, England). 43(6)

Objectives. To compare health-related quality of life (HRQoL), as measured by health utility, in patients with rheumatoid arthritis (RA) treated with adalimumab (a human anti-tumour necrosis factor (anti-TNF) monoclonal antibody) plus methotrexate or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74c618f72bc375bb407b815ca535bd3
https://pubmed.ncbi.nlm.nih.gov/15039494

Cost-effectiveness of Apligraf in the treatment of venous leg ulcers

Autor: R G, Sibbald, G W, Torrance, V, Walker, C, Attard, P, MacNeil

Publikováno v: Ostomy/wound management. 47(8)

Venous ulcers are the most common chronic wounds of the lower leg. Skin substitutes recently have been introduced to stimulate nonhealing wounds. To conduct an incremental cost-effectiveness analysis, a model was developed to compare the four-layer b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1cbd5d8a19471f20747c94d6ebe340ae
https://pubmed.ncbi.nlm.nih.gov/11890002

What should be reported in a methods section on utility assessment?

Autor: P F, Stalmeier, M K, Goldstein, A M, Holmes, L, Lenert, J, Miyamoto, A M, Stiggelbout, G W, Torrance, J, Tsevat

Publikováno v: Medical decision making : an international journal of the Society for Medical Decision Making. 21(3)

The measurement of utilities, or preferences, for health states may be affected by the technique used. Unfortunately, in papers reporting utilities, it is often difficult to infer how the utility measurement was carried out.To present a list of compo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::46e1fb39bbc2661bd2b5ba85bb5dedd0
https://pubmed.ncbi.nlm.nih.gov/11386627

PAR15 PRELIMINARY INVESTIGATION OF THE DISCRIMINATORY CAPACITY OF MEASURES OF LOW INTENSITY SYMPTOM STATE-ATTAINMENT USING THE WOMAC PAIN SUBSCALE SCORE IN PATIENTS TREATED WITH HYLAN G-F 20 FOR KNEE OSTEOARTHRITIS

Autor: V. Walker, Richard P. Polisson, Jean-Pierre Raynauld, Charles H. Goldsmith, D. Pericak, Mary J. Bell, Nicholas Bellamy, Peter Tugwell, G. W. Torrance

Publikováno v: Value in Health. 9(3):A28-A29

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe1a84665c596901860bda8c0ffdecc